VYNE – vyne therapeutics inc. (US:NASDAQ)

DELAYED


Volume Shares
1 Day Range
Volume Ratio
52 Week High
52 Week Low


VWAP
Today’s Volatility
20 Day Volatility
Open
Prior Close

YTD

1 Day

VYNE

SPY

QQQ

Swipe to see more

Main News & Impact Reports

Date

Time

Symbol

Headline

Impact

12/17

08:17 am

vyne

Form 425 VYNE Therapeutics Inc. Filed by: VYNE Therapeutics Inc.

High Report

Form 425 VYNE Therapeutics Inc. Filed by: VYNE Therapeutics Inc.

Report

12/17

08:16 am

vyne

Form 8-K VYNE Therapeutics Inc. For: Dec 17

High Report

Form 8-K VYNE Therapeutics Inc. For: Dec 17

Report

12/15

04:15 pm

vyne

Form 4 VYNE Therapeutics Inc. For: Dec 12 Filed by: BARBARI SHARON

High Report

Form 4 VYNE Therapeutics Inc. For: Dec 12 Filed by: BARBARI SHARON

Report

12/15

04:15 pm

vyne

Form 4 VYNE Therapeutics Inc. For: Dec 12 Filed by: LEPORE PATRICK G

High Report

Form 4 VYNE Therapeutics Inc. For: Dec 12 Filed by: LEPORE PATRICK G

Report

12/15

04:15 pm

vyne

Form 4 VYNE Therapeutics Inc. For: Dec 12 Filed by: Little Elisabeth Sandoval

High Report

Form 4 VYNE Therapeutics Inc. For: Dec 12 Filed by: Little Elisabeth Sandoval

Report

12/15

04:15 pm

vyne

Form 4 VYNE Therapeutics Inc. For: Dec 12 Filed by: Basta Steven L

High Report

Form 4 VYNE Therapeutics Inc. For: Dec 12 Filed by: Basta Steven L

Report

12/12

04:01 pm

vyne

Form 8-K VYNE Therapeutics Inc. For: Dec 12

Medium Report

Form 8-K VYNE Therapeutics Inc. For: Dec 12

Report

11/14

04:09 pm

vyne

Form SCHEDULE 13G/A VYNE Therapeutics Inc. Filed by: CITADEL ADVISORS LLC

Low Report

Form SCHEDULE 13G/A VYNE Therapeutics Inc. Filed by: CITADEL ADVISORS LLC

Report

11/14

03:23 pm

vyne

Form SCHEDULE 13G/A VYNE Therapeutics Inc. Filed by: EVENTIDE ASSET MANAGEMENT, LLC

Low Report

Form SCHEDULE 13G/A VYNE Therapeutics Inc. Filed by: EVENTIDE ASSET MANAGEMENT, LLC

Report

11/14

01:10 pm

vyne

Form SCHEDULE 13G/A VYNE Therapeutics Inc. Filed by: Cormorant Asset Management, LP

Low Report

Form SCHEDULE 13G/A VYNE Therapeutics Inc. Filed by: Cormorant Asset Management, LP

Report

11/12

04:13 pm

vyne

Form ARS VYNE Therapeutics Inc. For: Dec 31

Low Report

Form ARS VYNE Therapeutics Inc. For: Dec 31

Report

11/12

04:09 pm

vyne

Form DEF 14A VYNE Therapeutics Inc. For: Dec 12

Low Report

Form DEF 14A VYNE Therapeutics Inc. For: Dec 12

Report

11/6

04:01 pm

vyne

Form 10-Q VYNE Therapeutics Inc. For: Sep 30

High Report

Form 10-Q VYNE Therapeutics Inc. For: Sep 30

Report

11/6

08:02 am

vyne

Form 8-K VYNE Therapeutics Inc. For: Nov 06

Medium Report

Form 8-K VYNE Therapeutics Inc. For: Nov 06

Report

10/2

05:05 pm

vyne

Form 4 VYNE Therapeutics Inc. For: Sep 30 Filed by: Harsch Mutya

High Report

Form 4 VYNE Therapeutics Inc. For: Sep 30 Filed by: Harsch Mutya

Report

10/2

05:05 pm

vyne

Form 4 VYNE Therapeutics Inc. For: Sep 30 Filed by: Stuart Iain

High Report

Form 4 VYNE Therapeutics Inc. For: Sep 30 Filed by: Stuart Iain

Report

10/2

05:05 pm

vyne

Form 4 VYNE Therapeutics Inc. For: Sep 30 Filed by: Domzalski David

High Report

Form 4 VYNE Therapeutics Inc. For: Sep 30 Filed by: Domzalski David

Report

10/2

05:05 pm

vyne

Form 4 VYNE Therapeutics Inc. For: Sep 30 Filed by: Zeronda Tyler

High Report

Form 4 VYNE Therapeutics Inc. For: Sep 30 Filed by: Zeronda Tyler

Report

In short, News Quantified specializes in matching financial news with market data. We've analyzed 10s of millions of news events and know exactly which ones have an outsized impact on stock prices. So every single time a news item is released we know exactly what the average effect will be on a particular stock.